Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19()

BACKGROUND: This consensus aims to clarify the role of Dipeptidyl Peptidase-4 inhibitors (iDPP-4) in managing patients with diabetes during the COVID-19 pandemic. MATERIALS AND METHODS: A PubMed bibliographic search was carried out (December 2019–February 2021). Oxford methodology was used for the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrasco-Sánchez, Francisco Javier, Carretero-Anibarro, Enrique, Gargallo, Manuel Ángel, Gómez-Huelgas, Ricardo, Merino-Torres, Juan Francisco, Orozco-Beltrán, Domingo, Pines Corrales, Pedro José, Ruiz Quintero, Manuel Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SEEN and SED. Published by Elsevier España, S.L.U. 2022
Materias:
Consensus Document
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853860/
https://www.ncbi.nlm.nih.gov/pubmed/35353681
http://dx.doi.org/10.1016/j.endien.2022.02.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853860/
https://www.ncbi.nlm.nih.gov/pubmed/35353681
http://dx.doi.org/10.1016/j.endien.2022.02.008

Ejemplares similares